Asuka Horinouchi
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Evaluation of Puromycin-Induced Podocyte Injury and Protective Effects of Voclosporin Using Induced Pluripotent Stem Cells from a Patient with Nephrotic Syndrome Harboring an INF2 Variant.
Journal: Stem cells and development
Published: June 18, 2026
Postpartum TMA requiring dialysis with discordant complement tests: a case report.
Journal: CEN case reports
Published: March 14, 2026
Generation of a human-induced pluripotent stem cell line (NUMNi003-A) from a patient with autosomal dominant polycystic kidney disease harboring a PKD1 gene variant.
Journal: Stem cell research
Published: February 24, 2026
YS-1301 ameliorates crescentic glomerulonephritis by promoting immunoregulatory macrophages.
Journal: BMC nephrology
Published: December 10, 2025
Amnion-derived mesenchymal stem cells attenuate anti-GBM glomerulonephritis via regulation of neutrophil CD44 expression.
Journal: Stem cell research & therapy
Published: October 26, 2025
Atypical hemolytic uremic syndrome treated with anti-C5 antibody agent eculizumab, without genetic complement abnormalities.
Journal: Nagoya journal of medical science
Published: November 25, 2024
Intravenous Administration of Bone Marrow-Derived Mesenchymal Stem Cell, but not Adipose Tissue-Derived Stem Cell, Ameliorated the Neonatal Hypoxic-Ischemic Brain Injury by Changing Cerebral Inflammatory State in Rat.
Journal: Frontiers in neurology
Published: January 22, 2018
Identification of Meflin as a Potential Marker for Mesenchymal Stromal Cells.
Journal: Scientific reports
Published: July 13, 2015
Pristane-induced granulocyte recruitment promotes phenotypic conversion of macrophages and protects against diffuse pulmonary hemorrhage in Mac-1 deficiency.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: October 05, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026